Delivery Order SPE2DB22D2206-SPE2DB25FFW72
Award Date
2/28/25
Potential Completion Date
3/3/25
Potential Value
$10K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,653.97 firm fixed-price delivery order is for the supply of ONFI 2.5 MG/ML SUSPENSION 120ML, a pharmaceutical product. The award has an ultimate completion date of June 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $19,899.83, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ONFI 2.5 MG/ML SUSPENSION 120ML, a pharmaceutical product, with a completion date of May 4, 2023. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This award is not associated with a specific set-aside designation, indicating open...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide a pharmaceutical product - ONFI 2.5 MG/ML SUSPENSION 120ML. The contract has a ceiling value of $7,004.83 and a period of performance through April 15, 2024. This delivery order is part of a larger indefinite delivery contract between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply ONFI 2.5 MG/ML SUSPENSION 120ML, a prescription medication, to DLA facilities supporting the Department of Defense (DOD) worldwide. The contract has a ceiling value of $4,384.45 and is a Firm Fixed Price Delivery Order with a period of performance through June 21, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,137.10 delivery order is for ONFI 2.5 MG/ML SUSPENSION 120ML, a pharmaceutical product. The contract has an ultimate completion date of July 20, 2023 and a firm fixed price pricing type. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,525.16 firm fixed-price delivery order contract is for the supply of ONFI 10 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of January 16, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,742.32 firm-fixed-price delivery order is for the supply of 4567331064 - ONFI 10 MG TABLET 100S, a medical product. The contract has an ultimate completion date of February 21, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,694.52 firm fixed-price delivery order is for the provision of 4567082062 - ONFI 20 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of January 30, 2025 and does not include any set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...
This federal contract award, with ID SPE2DB22D3004|SPE2DB25FNM90, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,384.19 Firm Fixed Price Delivery Order is for the supply of 4566436494 ! ONFI 10 MG TABLET 100S, with a completion date of November 15, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award, valued at $3,367.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the provision of 4566476346 ! ONFI 10 MG TABLET 100S, with an ultimate completion date of November 19, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...